These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 27613110)

  • 21. Association of advanced glycation end products, evaluated by skin autofluorescence, with lifestyle habits in a general Japanese population.
    Isami F; West BJ; Nakajima S; Yamagishi SI
    J Int Med Res; 2018 Mar; 46(3):1043-1051. PubMed ID: 29322837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Skin accumulation of advanced glycation end products is increased in patients with an abdominal aortic aneurysm.
    Boersema J; de Vos LC; Links TP; Mulder DJ; Smit AJ; Zeebregts CJ; Lefrandt JD
    J Vasc Surg; 2017 Dec; 66(6):1696-1703.e1. PubMed ID: 28655550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum 25-hydroxyvitamin D
    Chen J; van der Duin D; Campos-Obando N; Ikram MA; Nijsten TEC; Uitterlinden AG; Zillikens MC
    Eur J Epidemiol; 2019 Jan; 34(1):67-77. PubMed ID: 30255328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of Advanced Glycation End Products with coronary Artery Calcification in Japanese Subjects with Type 2 Diabetes as Assessed by Skin Autofluorescence.
    Hangai M; Takebe N; Honma H; Sasaki A; Chida A; Nakano R; Togashi H; Nakagawa R; Oda T; Matsui M; Yashiro S; Nagasawa K; Kajiwara T; Takahashi K; Takahashi Y; Satoh J; Ishigaki Y
    J Atheroscler Thromb; 2016 Oct; 23(10):1178-1187. PubMed ID: 26961217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Skin autofluorescence predicts cardio-renal outcome in type 1 diabetes: a longitudinal study.
    Vélayoudom-Céphise FL; Rajaobelina K; Helmer C; Nov S; Pupier E; Blanco L; Hugo M; Farges B; Astrugue C; Gin H; Rigalleau V
    Cardiovasc Diabetol; 2016 Sep; 15(1):127. PubMed ID: 27585632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advanced glycation end products are associated with arterial stiffness in type 1 diabetes.
    Llauradó G; Ceperuelo-Mallafré V; Vilardell C; Simó R; Gil P; Cano A; Vendrell J; González-Clemente JM
    J Endocrinol; 2014 Jun; 221(3):405-13. PubMed ID: 24681829
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Skin autofluorescence (a marker for advanced glycation end products) and erectile dysfunction in diabetes.
    Kouidrat Y; Zaitouni A; Amad A; Diouf M; Desailloud R; Loas G; Lalau JD
    J Diabetes Complications; 2017 Jan; 31(1):108-113. PubMed ID: 27847146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-invasive measures of tissue autofluorescence are increased in Type 1 diabetes complications and correlate with a non-invasive measure of vascular dysfunction.
    Januszewski AS; Sachithanandan N; Karschimkus C; O'Neal DN; Yeung CK; Alkatib N; Jenkins AJ
    Diabet Med; 2012 Jun; 29(6):726-33. PubMed ID: 22211881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Skin Autofluorescence Is Associated with Diabetic Peripheral Neuropathy in Chinese Patients with Type 2 Diabetes: A Cross-Sectional Study.
    Wan L; Qin G; Yan W; Sun T
    Genet Test Mol Biomarkers; 2019 Jun; 23(6):387-392. PubMed ID: 31161820
    [No Abstract]   [Full Text] [Related]  

  • 30. Skin autofluorescence, a measure for accumulation of advanced glycation end products, positively associates with blood neutrophil and monocyte counts in the general population, and particularly in men with prediabetes.
    Groenen AG; Halmos B; van Zeventer IA; Salzbrunn JB; Mayer ML; La Rose ND; Nolte IM; Schuringa JJ; Huls G; Westerterp M
    Atherosclerosis; 2024 Aug; 395():117609. PubMed ID: 38878675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Skin autofluorescence predicts new cardiovascular disease and mortality in people with type 2 diabetes.
    Boersma HE; van Waateringe RP; van der Klauw MM; Graaff R; Paterson AD; Smit AJ; Wolffenbuttel BHR
    BMC Endocr Disord; 2021 Jan; 21(1):14. PubMed ID: 33435948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of skin autofluorescence, a marker of tissue advanced glycation end-products in peritoneal dialysis patients using standard and biocompatible glucose containing peritoneal dialysates.
    Vongsanim S; Fan S; Davenport A
    Nephrology (Carlton); 2019 Aug; 24(8):835-840. PubMed ID: 30298704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Significance of Non-invasive Skin Autofluorescence Measurement in Patients with Diabetes: A Systematic Review and Meta-analysis.
    Hosseini MS; Razavi Z; Ehsani AH; Firooz A; Afazeli S
    EClinicalMedicine; 2021 Dec; 42():101194. PubMed ID: 34841236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Skin autofluorescence is associated with severity of vascular complications in Japanese patients with Type 2 diabetes.
    Tanaka K; Tani Y; Asai J; Nemoto F; Kusano Y; Suzuki H; Hayashi Y; Asahi K; Nakayama M; Miyata T; Watanabe T
    Diabet Med; 2012 Apr; 29(4):492-500. PubMed ID: 21916970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Skin Autofluorescence, a Noninvasive Biomarker for Advanced Glycation End-Products, Is Associated With Prevalent Vertebral and Major Osteoporotic Fractures: The Rotterdam Study.
    Waqas K; Chen J; Koromani F; Trajanoska K; van der Eerden BC; Uitterlinden AG; Rivadeneira F; Zillikens MC
    J Bone Miner Res; 2020 Oct; 35(10):1904-1913. PubMed ID: 32463533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between cardiac tissue glycation and skin autofluorescence in patients with coronary artery disease.
    Hofmann B; Jacobs K; Navarrete Santos A; Wienke A; Silber RE; Simm A
    Diabetes Metab; 2015 Nov; 41(5):410-5. PubMed ID: 25553578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Skin autofluorescence and peripheral neuropathy four years later in type 1 diabetes.
    Rajaobelina K; Farges B; Nov S; Maury E; Cephise-Velayoudom FL; Gin H; Helmer C; Rigalleau V
    Diabetes Metab Res Rev; 2017 Feb; 33(2):. PubMed ID: 27235334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The relationship between advanced glycation end products and ocular circulation in type 2 diabetes.
    Hashimoto K; Kunikata H; Yasuda M; Ito A; Aizawa N; Sawada S; Kondo K; Satake C; Takano Y; Nishiguchi KM; Katagiri H; Nakazawa T
    J Diabetes Complications; 2016; 30(7):1371-7. PubMed ID: 27209548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Skin autofluorescence of advanced glycation end-products relates to new cardiovascular events in type 2 diabetes: A longitudinal observational study.
    Alkhami F; Borderie G; Foussard N; Larroumet A; Blanco L; Barbet-Massin MA; Ferriere A; Ducos C; Mohammedi K; Fawaz S; Couffinhal T; Rigalleau V
    Diabetes Metab; 2024 Mar; 50(2):101524. PubMed ID: 38346471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Weak Association between Skin Autofluorescence Levels and Prediabetes with an ILERVAS Cross-Sectional Study.
    Sánchez E; Kerkeni M; Hernández M; Gavaldà R; Rius F; Sauret A; Torres G; Bermúdez-López M; Fernández E; Castro-Boqué E; Purroy F; Mauricio D; Farràs-Sallés C; Buti M; Godoy P; Pamplona R; Lecube A
    Nutrients; 2022 Mar; 14(5):. PubMed ID: 35268075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.